InflaMed
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 60% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Supplement Facts — Evidence Check
10 mg
(91% DV)
✅ Within RDA (0.9× RDA of 11 mg)
📚 258 studies (Tier A: 6, B: 134)
40 mcg
(73% DV)
✅ Within RDA (0.7× RDA of 0.055 mg)
📚 172 studies (Tier A: 0, B: 67)
1 mg
(111% DV)
✅ 1.1× RDA — within safe limits
📚 36 studies (Tier A: 0, B: 11)
300 mcg
(889% DV)
📊 6.7× RDA — above typical dose (UL: 2 mg)
📚 2 studies — no high-quality reviews
500 mg
📊 Market median: 1000.0mg (2 products)
400 mg
📊 Market median: 450.0mg (254 products)
📚 240 studies (Tier A: 0, B: 100)
400 mg
📊 Market median: 200.0mg (136 products)
📚 3 studies — no high-quality reviews
📊 Market median: 375.0mg (171 products)
📚 30 studies (Tier A: 1, B: 14)
40 mg
📊 Market median: 250.0mg (337 products)
📚 125 studies (Tier A: 1, B: 41)
White Willow extract
50 mg
Other Ingredients
Hydroxypropyl Methylcellulose
Microcrystalline Cellulose
L-Leucine
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (99% of products)
Structure/Function (84% of products)
Nutrient (48% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested use As a dietary supplement, 2 capsules one or two times daily between meals, or as directed by a healthcare practitioner.
🧪 Formulation Notes
A synergistic blend of herbs, nutrients, and proteolytic enzymes which provide nutritional support for connective tissue and joint tissue.
Connective tissue and joint health
Hypoallergenic
Additional Information
Keep in a cool, dry place, tightly capped.
Product Details
UPC / SKU
7 13947 74730 2
DSLD Entry Date
2021-12-18
Product Type
Other Combinations
Form
Capsule
Brand
Allergy Research Group
DSLD ID
258223
Data Updated
2026-04-11
Research Evidence
397
Research Sources
55
Avg Quality Score
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A
Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
A
Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Compare Similar Products
Zinc Picolinate 30 mg
VitaCeutical Labs
100
Opti-Zinc 30
Douglas Laboratories
100
Zinc Picolinate
Cardiovascular Research
100
Zinc Picolinate 25 mg
Kirkman
100
Zinc 20 mg
Kirkman
100